DalsnaFinance › IPOs › Innate Pharma › IPO
Innate Pharma SA completed its initial public offering on NASDAQ on October 17, 2019, pricing at $5.50 a share.
| Ticker | IPHA |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | October 17, 2019 |
| Offering price | $5.50 |
| Shares offered | 12,500,000 |
| Total raised | $69M |
Innate Pharma SA sold 12,500,000 shares at $5.50 each on NASDAQ. Multiplied out, that is $68.8 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $69 million total recorded for the deal.
Innate Pharma SA — quote, profile and latest news →
Source: SEC EDGAR filings for Innate Pharma SA. This page is general information, not investment advice.